Credelio Plus RSS Authorised This medicine is authorised for use in the European Union lotilaner / milbemycin oximeMedicineVeterinaryAuthorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Credelio Plus More information on Credelio Plus Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Credelio Plus : EPAR - Medicine overview English (EN) (81.94 KB - PDF)First published: 04/08/2021 Last updated: 11/06/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View español (ES) (81.97 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View čeština (CS) (93.99 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View dansk (DA) (83.34 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View français (FR) (82.44 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View íslenska (IS) (83.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View italiano (IT) (82.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View magyar (HU) (94.15 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Malti (MT) (95.95 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View norsk (NO) (82 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View polski (PL) (95.62 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View português (PT) (83.01 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View română (RO) (94.17 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Suomi (FI) (81.54 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View svenska (SV) (82.05 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Product information Credelio Plus : EPAR - Product information English (EN) (81.49 KB - PDF)First published: 04/08/2021 Last updated: 11/06/2024 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View español (ES) (81.51 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View čeština (CS) (92.48 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View dansk (DA) (82.05 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Deutsch (DE) (81.72 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View eesti keel (ET) (81.22 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View ελληνικά (EL) (91.79 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View français (FR) (81.63 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View hrvatski (HR) (91.56 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View íslenska (IS) (81.52 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Gaeilge (GA) (81.36 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View italiano (IT) (81.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View latviešu valoda (LV) (92.14 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View magyar (HU) (92.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Malti (MT) (93.86 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Nederlands (NL) (81.15 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View norsk (NO) (81.52 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View polski (PL) (93.22 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View português (PT) (82.53 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View română (RO) (91.73 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenčina (SK) (81.75 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenščina (SL) (81.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Suomi (FI) (81.11 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View svenska (SV) (81.47 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Credelio Plus : EPAR - All authorised presentations English (EN) (81.94 KB - PDF)First published: 04/08/2021 Last updated: 11/06/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View español (ES) (81.97 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View čeština (CS) (93.99 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View dansk (DA) (83.34 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View français (FR) (82.44 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View íslenska (IS) (83.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View italiano (IT) (82.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View magyar (HU) (94.15 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Malti (MT) (95.95 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View norsk (NO) (82 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View polski (PL) (95.62 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View português (PT) (83.01 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View română (RO) (94.17 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Suomi (FI) (81.54 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View svenska (SV) (82.05 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Product details Name of medicine Credelio Plus Active substance lotilanermilbemycin oxime International non-proprietary name (INN) or common name lotilaner / milbemycin oxime Pharmacotherapeutic groupEndectocides Authorisation details EMA product number EMEA/V/C/005325 Assessment history Expand section Collapse section Changes since initial authorisation of medicine CVMP post-authorisation summary of positive opinion for Credelio PlusAdopted Reference Number: EMA/CVMP/903852/2022 English (EN) (145.39 KB - PDF)First published: 09/12/2022 View Initial marketing authorisation documents Credelio Plus : EPAR - Public assessment reportAdopted Reference Number: EMA/160155/2021 English (EN) (81.49 KB - PDF)First published: 04/08/2021 Last updated: 11/06/2024 View CVMP summary of positive opinion for Credelio PlusAdopted Reference Number: EMA/CVMP/65055/2021 English (EN) (65.98 KB - PDF)First published: 19/02/2021 View News on Credelio Plus Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 November 202507/11/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 9-10 September 202512/09/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 November 202310/11/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 December 202209/12/2022 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 May 202213/05/2022 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-17 February 202119/02/2021 More information on Credelio Plus Credelio, Lotimax, Credelio Plus - opinion on variation to marketing authorisation This page was last updated on 11/06/2024 Share this page